About Salivio Pharma
Salivio Pharma is a Healthcare company based in Dehradun (India) founded in 2022. Sourcing, distributing, and marketing quality pharmaceutical products worldwide. It operates on a B2B model. Its Indian entity Salivio Pharma Private Limited reported revenue of ₹8.5 Lakh. Salivio Pharma offers products and services including Antacid, Antialergic, Antibiotic, Antiulcer, and Appetiser. Its focus areas include Pharmaceuticals, Quality Assurance, Technology Transfer and Drug Distribution. Similar companies include Entero Healthcare, Keimed and Sandor Medicaids; 3 of its 3 listed similar companies have raised funding.
Company details
Salivio Pharma is a pharmaceutical company based in Dehradun, India, specializing in sourcing, distributing, and marketing affordable generic and innovative medications. They focus on ensuring safety, efficacy, and accessibility of drugs through services like drug development, technology transfer, and quality assurance. The company aims to make high-quality medicines available globally while mentoring professionals and reviewing quality systems.
- Headquarters Dehradun, India
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website saliviopharma.com
- Legal Name Salivio Pharma Private Limited
- Date of Incorporation 25 Nov, 2016
- Jurisdiction Dehradun, Uttarakhand, India
- Annual Revenue₹8.5 Lakh
FY 2025 · +19% YoY
- Net Profit₹21,927
FY 2025 · 3% margin
- EBITDA₹66,393
FY 2025 · 8% margin
Associated legal entities of Salivio Pharma
Salivio Pharma operates through Salivio Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Salivio Pharma Private Limited CIN U24304UR2016PTC007422 | Active | 25 Nov 2016 | Dehradun, Uttarakhand | ₹0.1 Cr | 3 | View details |
Products & Services of Salivio Pharma
Salivio Pharma offers a comprehensive portfolio of products and services, including Antacid, Antialergic, Antibiotic, Antiulcer, and Appetiser.
Relieves stomach acidity and heartburn symptoms effectively.
Treats allergic reactions and related symptoms.
Fights bacterial infections to promote health.
Manages ulcers and gastrointestinal issues.
Stimulates appetite for better nutrition intake.
Addresses digestive system disorders.
Supports liver health and function.
Provides essential vitamins for overall wellness.
Alleviates pain and inflammation symptoms.
Board of directors of Salivio Pharma Private Limited (Salivio Pharma)
Salivio Pharma Private Limited is the primary company behind Salivio Pharma. The board of Salivio Pharma Private Limited currently have 3 directors; the longest-serving is Sushil Singh, appointed in 2016. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sushil Singh DIN 07640393 | Director | 25 Nov 2016 | 9 yrs 11 mo | Salivio Pharma Private Limited |
| Manas Singh DIN 07738988 | Director | 14 Feb 2017 | 9 yrs 8 mo | Salivio Pharma Private Limited |
| Arushi Singh DIN 09848974 | Director | 10 Dec 2022 | 3 yrs 10 mo | Salivio Pharma Private Limited |
Financials of Salivio Pharma
Figures of Salivio Pharma Private Limited, the primary company behind Salivio Pharma, for FY 2025. Revenue was ₹8.5 Lakh (+19% year on year). Net profit was ₹21,927 (3% margin). EBITDA was ₹66,393 (8% margin). Revenue has grown at a compounded annual rate of +16% over three years and +51% over five years.
- ₹8.5 LakhRevenue · FY 2025 · +19% YoY
- ₹21,927Net profit · 3% margin
- ₹66,393EBITDA · 8% margin
- ₹10 LakhPaid-up capital
- +16%Revenue CAGR, 3 years
- +51%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Salivio Pharma Private Limited are on its company page.
Detailed financial statements for Salivio Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Salivio Pharma
Salivio Pharma has 3 listed similar companies in our database, 3 of them funded. They include Entero Healthcare, Keimed and Sandor Medicaids.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| enterohealthcare.com | 2018 | Mumbai, India | $59.67M | 817 | India's leading healthcare products distribution platform | |
| keimed.com | 2000 | Hyderabad, India | $16.62M | 588 | Temperature-sensitive medicines are distributed via cold chain logistics by Keimed. | |
| sandor.co.in | 1995 | Hyderabad, India | $8.98M | 161 | Provider of medical equipment, devices, and drugs distribution services |
Detailed similar companies of Salivio Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Salivio Pharma
Salivio Pharma was founded in 2022.
Salivio Pharma is headquartered in Dehradun, India. It is registered at Dehradun, Uttarakhand, India.
The primary company behind Salivio Pharma, Salivio Pharma Private Limited, reported revenue of ₹8.5 Lakh for FY 2025, up 19% year on year.
Salivio Pharma is a pharmaceutical company based in Dehradun, India, specializing in sourcing, distributing, and marketing affordable generic and innovative medications. They focus on ensuring safety, efficacy, and accessibility of drugs through services like drug development, technology transfer, and quality assurance. The company aims to make high-quality medicines available globally while mentoring professionals and reviewing quality systems.
Salivio Pharma's top competitors include Entero Healthcare, Keimed and Sandor Medicaids.
Salivio Pharma offers Antacid, Antialergic, Antibiotic, Antiulcer, and 5 more products and services.
Salivio Pharma operates through Salivio Pharma Private Limited.
The legal entities of Salivio Pharma currently have 3 directors, including Manas Singh, Arushi Singh, Sushil Singh.